![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Y Kitada, M Kobayashi, A Narimatsu and Y Ohizumi
Research Center, Mitsubishi Kasei Corporation, Yokohama, Japan.
In the present study we have analyzed a likely biochemical mechanism underlying the Ca++-sensitizing action of MCI-154 (6-[4-(4'- pyridyl)aminophenyl)-4,5-dihydro-3(2H)-pyridazinone hydrochloride), a novel cardiotonic agent, on the contractile protein system. MCI-154 (10(-7) to 10(-4) M) enhanced the tension development induced by -log molar-free Ca++ concentration (pCa) 5.8 in chemically skinned fiber from the canine right ventricular muscle in a concentration-dependent manner. At pCa 7.0, MCI-154 (10(-7) to 10(-4) M) markedly increased adenosine triphosphatase (ATPase) activities of canine myofibrils and reconstituted actomyosin. In myofibrils and reconstituted actomyosin, MCI-154 (10(-7) to 10(-4) M) caused a parallel shift of the pCa-ATPase activity relation curve to the left without affecting the maximum activity, suggesting an increase in Ca++ sensitivity. MCI-154 (10(-8) to 10(-4) M) had little effect on actin-activated, Mg++, Ca++ and (K+, EDTA)-ATPase activities of myosin. Ca++ binding to cardiac myofibrils or purified cardiac troponin was increased by 10(-4) M MCI-154. These results suggest that MCI-154 enhances Ca++ binding to cardiac troponin C to elevate the Ca++ sensitivity of myofilaments and thus may cause a positive inotropic action in cardiac muscle. MCI-154 may provide a valuable tool for studying the molecular mechanism by which Ca++ regulates the contractile system.
This article has been cited by other articles:
|
|
 |
|
  S. Takahashi, S. Cho, T. Hara, H. Ureshino, S. Tomiyasu, and K. Sumikawa The Interaction of MCI-154, a Calcium Sensitizer, and Isoflurane on Systemic and Coronary Hemodynamics in Chronically Instrumented Dogs Anesth. Analg., January 1, 2004; 98(1): 30 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Onishi, K. Sekioka, R. Ishisu, Y. Abe, H. Tanaka, M. Nakamura, Y. Ueda, and T. Nakano MCI-154, a Ca2+ sensitizer, decreases the oxygen cost of contractility in isolated canine hearts Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1688 - H1695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Teramura, T. Yamakado, M. Maeda, and T. Nakano Effects of MCI-154, a Calcium Sensitizer, on Left Ventricular Systolic and Diastolic Function in Pacing-Induced Heart Failure in the Dog Circulation, February 4, 1997; 95(3): 732 - 739. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Sata, S. Sugiura, H. Yamashita, H. Fujita, S.-i. Momomura, and T. Serizawa MCI-154 Increases Ca2+ Sensitivity of Reconstituted Thin Filament : A Study Using a Novel In Vitro Motility Assay Technique Circ. Res., April 1, 1995; 76(4): 626 - 633. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
